EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Efficacy of diabetes‐specific partial meal replacement on glycemic and weight control in type 2 diabetes: A randomized controlled trial

Lew Leong Chen, Noorlaili Mohd Tohit, Arimi Fitri Mat Ludin iD, Zahara Abdul Manaf, Alicia Wong, Kwan Lee Kuan, Han Wan Chien, Suzana Shahar

Diabetes, Obesity and Metabolism · 2025

DOI: 10.1111/dom.16446 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Lew Leong Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Healthy Ageing and Wellness, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Glycemic Control, Obesity, Overweight. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Powerlife (M) Sdn. Bhd, National University of Malaysia Faculty of Medicine Fundamental Grant (GFFP).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To evaluate the efficacy of a diabetes‐specific formula (DSF)‐based partial meal replacement (PMR) in improving glycemic control, weight, and underlying hormonal changes among participants with type 2 diabetes and overweight or obesity compared to dietary consultation. Materials and Methods This 12‐week, parallel randomized controlled trial was conducted at Hospital Canselor Tuanku Muhriz, National University of Malaysia, from February 2022 to March 2024. Adults aged 20–65 years with type 2 diabetes [haemoglobin A1c (HbA1c) ≥7.5%] and overweight or obesity were randomized into two groups: PMR with DSF (Metabolic+ Sauver) plus dietary consultation (treatment group) or dietary consultation alone (control group). The primary endpoint was mean change in HbA1c at week 12.

Results

Among 156 participants (mean age 52.2 ± 9.7 years), 141 completed the 12‐week intervention. The treatment group had a greater HbA1c reduction compared to controls (−0.83% vs. ‐0.19%; MD: −0.63%; 95% CI: −1.00, −0.27; p < 0.001). A significantly higher proportion of the treatment group participants (61.4%) achieved clinically significant HbA1c reduction (≥0.5%) compared to controls (42.3%, p = 0.023). Fasting glucose, insulin, and anthropometric measurements also significantly improved in the treatment group compared to controls. Subsample analysis on hormonal changes revealed significant improvements in adiponectin levels among the treatment group.

Conclusion

This study demonstrated that PMR with DSF significantly improved glycemic and weight management in participants with type 2 diabetes and overweight or obesity. Adiponectin levels increased in the treatment group, correlating with improved glycemic control. No adverse events were observed on liver and kidney profiles, highlighting its potential as a safe and effective approach for diabetes management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Glycemic ControlObesityOverweightHumansMiddle AgedMaleFemaleAdultGlycated HemoglobinAgedBlood GlucoseTreatment OutcomeWeight LossYoung AdultMalaysiaMeals

Stichwörter der Autor:innen

dietary interventioneffectivenessglycaemic controlrandomised trialtype 2 diabetesweight management

Substanzen

Glycated HemoglobinBlood Glucosehemoglobin A1c protein, human

Autor:innen und Institutionen

  • Center for Healthy Ageing and Wellness, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
  • Biomedical Science Programme, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
  • Department of Family Medicine, Faculty of Medicine, University Kebangsaan Malaysia Medical Centre (UKMMC), Kuala Lumpur, Malaysia.
  • Dietetic Programme, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
  • Alpro Academy, Alpro Group, Sendayan Techvalley, Seremban, Malaysia.

ORCID-Profile: Arimi Fitri Mat Ludin

Förderung

  • Powerlife (M) Sdn. Bhd
  • National University of Malaysia Faculty of Medicine Fundamental Grant (GFFP)

Zitieren

APA

Chen, L. L., Tohit, N. M., Ludin, A. F. M., Manaf, Z. A., Wong, A., Kuan, K. L., Chien, H. W., & Shahar, S. (2025). Efficacy of diabetes‐specific partial meal replacement on glycemic and weight control in type 2 diabetes: A randomized controlled trial. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16446

Vancouver

Chen LL, Tohit NM, Ludin AFM, Manaf ZA, Wong A, Kuan KL, et al. Efficacy of diabetes‐specific partial meal replacement on glycemic and weight control in type 2 diabetes: A randomized controlled trial. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16446

BibTeX
@article{Chen2025,
  author = {Chen, Lew Leong and Tohit, Noorlaili Mohd and Ludin, Arimi Fitri Mat and Manaf, Zahara Abdul and Wong, Alicia and Kuan, Kwan Lee and Chien, Han Wan and Shahar, Suzana},
  title = {Efficacy of diabetes‐specific partial meal replacement on glycemic and weight control in type 2 diabetes: A randomized controlled trial},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  doi = {10.1111/dom.16446}
}
Kostenlos starten →